Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06935123 · ClinicalTrials.gov registry record · Phase 1
Impact of Nutritional Supplementation on Sleep Quality
A Phase 1 study, sponsored by Pharmavite.
- Completed
- Registry status
- Phase 1
- Development phase
- 376
- Enrollment target
NCT06935123: Completed Phase 1 study, sponsored by Pharmavite.
NCT06935123 is a Phase 1 study that has completed, run by Pharmavite. The registered enrollment target is 376 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (527% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06935123, a Phase 1 study, has completed, sponsored by Pharmavite.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 376 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled, 5-arm parallel-group study to evaluate the effects of 4 nutritional supplements on sleep over a 12 week period in healthy U.S. adults.
Primary Outcome
Perceived sleep quality
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Sleep Supplements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2025-05-15 |
| Est. Completion | 2025-10-31 |
| Phase | Phase 1 |
What the finished NCT06935123 record still lists
NCT06935123 is an interventional study that assigns participants to a tested intervention. The registered 376 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (527% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06935123 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06935123 about?
NCT06935123 is a clinical study titled "Impact of Nutritional Supplementation on Sleep Quality". This is a randomized, double-blind, placebo-controlled, 5-arm parallel-group study to evaluate the effects of 4 nutritional supplements on sleep over a 12 week period in healthy U.S. adults.
What is the current status of trial NCT06935123?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 376 participants. The study started on 2025-05-15. Estimated completion is 2025-10-31.
What interventions are being tested in trial NCT06935123?
The interventions under investigation include: Placebo (OTHER), Sleep Supplements (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06935123?
This trial is sponsored by Pharmavite, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06935123's enrollment target sits among peer trials
376 84th of 2000 higher than 1,917 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03102125 · 376 participants · Phase 4
Allograft Dysfunction in Heart Transplant
- NCT05055297 · 376 participants · NA
SELUTION4BTK Trial
- NCT05912647 · 376 participants · NA
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
- NCT05963971 · 376 participants · NA
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI